Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Improving Genetic Risk Scores for Cardiovascular Diseases
EF 2021-22
Résumé
Coronary
Artery Disease (CAD) is the leading cause of death worldwide despite the
availability of extensive therapeutic and lifestyle interventions. Thus,
producing a high societal and economic burden. Consequently, CAD warrants
research into pre-emptive diagnosing and intervention. Over the past
decade, extensive genetic studies have identified many genetic variants
that are associated with CAD. It is now possible to use all of these
genetic variants to determine an individual’s relative susceptibility and
predisposition to CAD. Our research focuses on regrouping certain genetic
variants together according to their association with specific metabolic
processes. For example, partitioning genetic variants according to their
association with cholesterol yields a cholesterol-focused variant subset
and a subset free of cholesterol variants. Our research also investigates
the relationship between risk factors for CAD and these genetic variants.
We can then assess whether these smaller variant subsets lead to an
improvement in our ability to accurately assess a patient’s risk for CAD.
These results may also shed light on the causes of CAD and pave the way
for novel therapeutic targets.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
481146
Name
Desrochers Justine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Improving Genetic Risk Scores for Cardiovascular Diseases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Coronary Artery Disease; Genetic Risk Score; Genome Wide Association Study; Low-Density Lipoprotein Cholesterol; Myocardial Infarction; Single Nucleotide Polymorphism
Abstract
<html>
<head>
</head>
<body>
<span align="start" style="letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none"><font color="rgb(0, 0, 0)" face="Verdana, Arial, Helvetica, sans-serif" size="12.8px">Coronary
Artery Disease (CAD) is the leading cause of death worldwide despite the
availability of extensive therapeutic and lifestyle interventions. Thus,
producing a high societal and economic burden. Consequently, CAD warrants
research into pre-emptive diagnosing and intervention. Over the past
decade, extensive genetic studies have identified many genetic variants
that are associated with CAD. It is now possible to use all of these
genetic variants to determine an individual’s relative susceptibility and
predisposition to CAD. Our research focuses on regrouping certain genetic
variants together according to their association with specific metabolic
processes. For example, partitioning genetic variants according to their
association with cholesterol yields a cholesterol-focused variant subset
and a subset free of cholesterol variants. Our research also investigates
the relationship between risk factors for CAD and these genetic variants.
We can then assess whether these smaller variant subsets lead to an
improvement in our ability to accurately assess a patient’s risk for CAD.
These results may also shed light on the causes of CAD and pave the way
for novel therapeutic targets.</font></span>
</body>
</html>
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Desrochers, Justine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~